Jinrui Foundation Biotech Co., Ltd. Receives FDA Approval to Conduct Phase I Cli

May27, 2024, Jinrui Foundation Biotech Co , Ltd announced today that its Investigational New Drug (IND 161353) ap

Sichuan Jinrui Wins Deyang 12th Municipal Academician Workstation Approval

The Promotion Conference for the Construction of 2023 Deyang Academician (Expert) Workstations was held on June 19

[Good News]Jinrui Jiye Earns Sichuan SRUI SME Certification

In December 2023, the Sichuan Provincial Department of Economy and Information Technology awarded certification plaq

[Good News]Our Company Obtains National High-tech Enterprise Qualification

On November 27, 2023, Chengdu Jinrui Jiye was granted the National High-tech Enterprise Certificate (Certificate No

JinRui Foundation Biotechnology Co., Ltd Granted IND in China

JinRui Foundation Biotechnology Co , Ltd (JRF) announced today that they will be proceeding with clinical trials of JRF-103, a drug for treating advanced solid tumors, after receiving an Investigational New Drug (IND) designation from the Center for Drug